Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis

Published:2016-11-22 Issue:3 Volume:60 Page:146-154
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Steimbach Laiza M.¹,Tonin Fernanda S.¹,Virtuoso Suzane¹²,Borba Helena H. L.¹,Sanches Andréia C. C.²,Wiens Astrid¹,Fernandez-Llimós Fernando³,Pontarolo Roberto¹

Affiliation:

1. Department of Pharmacy; Pharmaceutical Sciences Postgraduate Research Program; Federal University of Paraná; Curitiba Brazil

2. Department of Medical and Pharmaceutical Sciences; West-Stadual University of Parana (UNIOESTE); Cascavel Brazil

3. Department of Social Pharmacy; Research Institute for Medicines (iMed. ULisboa); Faculty of Pharmacy; University of Lisboa; Lisbon Portugal

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/myc.12585/fullpdf

Reference74 articles.

1. Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting;Bes;Pediatr Infect Dis J,2014

2. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study;Wisplinghoff;Clin Infect Dis,2004

3. Amphotericin B formulations: a comparative review of efficacy and toxicity;Hamill;Drugs,2013

4. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee;Vincent;JAMA,1995

5. Invasive fungal infection in immunocompromised patients;Garcia-Ruiz;Rev Iberoam Micol,2004

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paving the way for affordable and equitable liposomal amphotericin B access worldwide;The Lancet Global Health;2024-09

2. Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method;Frontiers in Pharmacology;2024-06-28

3. Amphotericin B in the Era of New Antifungals: Where Will It Stand?;Journal of Fungi;2024-04-10

4. Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data;Journal of Neurology;2024-01-30

5. The Glomerulus: Mechanisms and Patterns of Injury;Reference Module in Biomedical Sciences;2024